Covance, Inc. is expanding its analytical and stability services facility in Madison, WI, doubling capacity for large-scale, long-term stability and release programs for preclinical, clinical, and chemistry, manufacturing, and control (CMC) development of pharmaceutical and animal health products.
The expanded facility includes upgraded stability chambers equipped with high-density tracked shelving to help increase pharmaceutical analysis service capacity and utilization, and will have as many as ten walk-in chambers and several reach-in chambers. The facility will also provide space for further expansion.
"Covance is committed to providing world-class CMC analytical services for our clients to provide the highest quality data and reduce developments timelines," said Henry Hummel, vice president and general manager, Madison sites, Covance. "Together with our integrated discovery, preclinical, and clinical service offerings and dedicated program management team, we can now offer CMC analytical services as part of an entire molecule development program."
Magazine
